GGOCX
Price
$22.54
Change
+$0.22 (+0.99%)
Updated
Oct 8 closing price
Net Assets
1.02B
VMGIX
Price
$116.86
Change
+$1.26 (+1.09%)
Updated
Oct 8 closing price
Net Assets
33.08B
Interact to see
Advertisement

GGOCX vs VMGIX

Header iconGGOCX vs VMGIX Comparison
Open Charts GGOCX vs VMGIXBanner chart's image
Goldman Sachs Mid Cap Growth C
Price$22.54
Change+$0.22 (+0.99%)
VolumeN/A
Net Assets1.02B
Vanguard Mid-Cap Growth Index Investor
Price$116.86
Change+$1.26 (+1.09%)
VolumeN/A
Net Assets33.08B
GGOCX vs VMGIX Comparison Chart in %
View a ticker or compare two or three
VS
GGOCX vs. VMGIX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGOCX is a StrongBuy and VMGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGIX has more cash in the bank: 33.1B vs. GGOCX (1.02B). VMGIX pays higher dividends than GGOCX: VMGIX (0.50) vs GGOCX (0.00). GGOCX was incepted earlier than VMGIX: GGOCX (26 years) vs VMGIX (19 years). GGOCX (2.12) is less costly to investors than VMGIX (0.19). GGOCX is a more actively managed with annual turnover of: 63.00 vs. VMGIX (21.00). GGOCX has a lower initial minimum investment than VMGIX: GGOCX (1000) vs VMGIX (3000). VMGIX annual gain was more profitable for investors over the last year : 20.31 vs. GGOCX (8.35). VMGIX return over 5 years is better than : 56.01 vs. GGOCX (-86.94).
GGOCXVMGIXGGOCX / VMGIX
Total Expense Ratio1.910.191,005%
Annual Report Gross Expense Ratio2.120.191,116%
Fund Existence26 years19 years-
Gain YTD9.46515.87560%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B33.1B3%
Annual Yield % from dividends0.000.50-
Returns for 1 year8.3520.3141%
Returns for 3 years38.3868.3156%
Returns for 5 years-86.9456.01-155%
Returns for 10 years-95.07192.30-49%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LPTX0.750.12
+19.75%
Leap Therapeutics
CRI30.191.22
+4.21%
Carter's
FACT10.30N/A
N/A
Fact II Acquisition Corp
USB46.99-0.51
-1.07%
US Bancorp
CAR146.32-2.90
-1.94%
Avis Budget Group